Andreana Foresta Selected Research

Hypoglycemic Agents (Hypoglycemics)

1/2023	Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, and Sodium-Glucose Cotransporter-2 Inhibitors and COVID-19 Outcomes.
1/2022	Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreana Foresta Research Topics

Disease

2	COVID-19 01/2023 - 01/2022
2	Myocardial Infarction 01/2022 - 01/2022
2	Stroke (Strokes) 01/2022 - 04/2021
1	Ischemic Stroke 02/2024
1	Inflammation (Inflammations) 01/2023
1	ST Elevation Myocardial Infarction 10/2022
1	Non-ST Elevated Myocardial Infarction 10/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Heart Failure 01/2022
1	Neoplasms (Cancer) 01/2022
1	Unstable Angina 01/2022
1	Thromboembolism 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Atrial Fibrillation 04/2021
1	Liver Diseases (Liver Disease) 04/2021

Drug/Important Bio-Agent (IBA)

2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2022
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023 - 01/2022
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 01/2022
2	AnticoagulantsIBA 01/2022 - 04/2021
1	Insulin (Novolin)FDA Link 02/2024
1	SodiumIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	ORALIT (ORS)IBA 10/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Ramipril (Altace)FDA LinkGeneric 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022

Therapy/Procedure

1	Therapeutics 01/2023
1	Secondary Prevention 01/2022